{"denoms":[{"counts":[{"groupId":"BG000","value":"743"},{"groupId":"BG001","value":"743"},{"groupId":"BG002","value":"1486"}],"units":"Participants"}],"groups":[{"description":"Participants received trastuzumab, 6 mg/kg, IV, Q3W, as a maintenance dose for 14 cycles (1 cycle = 21 days) or until disease recurrence or unacceptable toxicity which ever occurs first.","id":"BG000","title":"Trastuzumab"},{"description":"Participants received trastuzumab emtansine, 3.6 mg/kg, IV, Q3W for 14 cycles (1 cycle = 21 days) or until disease recurrence or unacceptable toxicity which ever occurs first.","id":"BG001","title":"Trastuzumab Emtansine"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"675"},{"groupId":"BG001","value":"685"},{"groupId":"BG002","value":"1360"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"68"},{"groupId":"BG001","value":"58"},{"groupId":"BG002","value":"126"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"740"},{"groupId":"BG001","value":"741"},{"groupId":"BG002","value":"1481"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"107"},{"groupId":"BG001","value":"91"},{"groupId":"BG002","value":"198"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"543"},{"groupId":"BG001","value":"579"},{"groupId":"BG002","value":"1122"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"93"},{"groupId":"BG001","value":"73"},{"groupId":"BG002","value":"166"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"50"},{"groupId":"BG001","value":"36"},{"groupId":"BG002","value":"86"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"64"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"129"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"21"},{"groupId":"BG002","value":"40"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"530"},{"groupId":"BG001","value":"551"},{"groupId":"BG002","value":"1081"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"77"},{"groupId":"BG001","value":"69"},{"groupId":"BG002","value":"146"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"}],"populationDescription":"Intent-to-treat (ITT) population included all participants who were randomized to the study regardless of whether they received any study treatment."}